๐”– Scriptorium
โœฆ   LIBER   โœฆ

๐Ÿ“

Fragment-Based Methods in Drug Discovery

โœ Scribed by Anthony E. Klon (eds.)


Publisher
Humana Press
Year
2015
Tongue
English
Leaves
227
Series
Methods in Molecular Biology 1289
Edition
1
Category
Library

โฌ‡  Acquire This Volume

No coin nor oath required. For personal study only.

โœฆ Synopsis


This volume covers the techniques necessary for a successful fragment-based drug design project, beginning from defining the problem in terms of preparing the protein model, identifying potential binding sites, and the consideration of various candidate fragments for simulation. The second part discusses the technical aspects that various methods have used to simulate fragment binding to a target protein by using Monte Carlo, molecular dynamics, and docking algorithms. After simulations, fragments are assembled into molecules using a variety of approaches, which are explored next. A discussion of design strategies and consideration of drug-like properties is included as part of the design process at this stage. Finally, several examples of successful fragment-based drug design projects are presented. Written for the Methods in Molecular Biology series, this work contains the kind of detailed description and implementation advice to encourage success in the lab.

Practical and cutting-edge, Fragment-Based Methods in Drug Discovery takes into account the great accomplishments in the field to provide an ideal guide for researchers continuing to investigate this exciting area of pharmacological study.

โœฆ Table of Contents


Front Matter....Pages i-ix
Front Matter....Pages 1-1
Front Matter....Pages 3-12
Front Matter....Pages 13-21
Front Matter....Pages 23-29
Back Matter....Pages 31-41
....Pages 43-53

โœฆ Subjects


Pharmacology/Toxicology


๐Ÿ“œ SIMILAR VOLUMES


Fragment-Based Methods in Drug Discovery
โœ Anthony E. Klon (eds.) ๐Ÿ“‚ Library ๐Ÿ“… 2015 ๐Ÿ› Humana Press ๐ŸŒ English

<p><p>This volume covers the techniques necessary for a successful fragment-based drug design project, beginning from defining the problem in terms of preparing the protein model, identifying potential binding sites, and the consideration of various candidate fragments for simulation. The second par

Fragment-Based Drug Discovery
โœ Steven Howard, Chris Abell (eds.) ๐Ÿ“‚ Library ๐Ÿ“… 2015 ๐Ÿ› Royal Society of Chemistry ๐ŸŒ English

<P>Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is

Fragment-Based Drug Discovery
โœ Steven Howard, Chris Abell (eds.) ๐Ÿ“‚ Library ๐Ÿ“… 2015 ๐Ÿ› Royal Society of Chemistry ๐ŸŒ English

<P>Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is

Fragment-based Approaches in Drug Discov
โœ Wolfgang Jahnke, Daniel A. Erlanson (Editors), Raimund Mannhold, Hugo Kubinyi, G ๐Ÿ“‚ Library ๐Ÿ“… 2006 ๐Ÿ› Wiley-VCH ๐ŸŒ English

This first systematic summary of the impact of fragment-based approaches on the drug development process provides essential information that was previously unavailable. Adopting a practice-oriented approach, this represents a book by professionals for professionals, tailor-made for drug developers i

Fragment-Based Drug Discovery: A Practic
โœ Edward Zartler, Michael Shapiro ๐Ÿ“‚ Library ๐Ÿ“… 2008 ๐Ÿ› Wiley ๐ŸŒ English

Fragment-based drug discovery (FBDD) is a new paradigm in drug discovery that utilizes very small molecules - fragments of larger molecules. It is a faster, cheaper, smarter way to do drug discovery, as shown by the number of pharmaceutical companies that have embraced this approach and the biotechn